33184027|t|Distinct Poly(A) nucleases have differential impact on sut-2 dependent tauopathy phenotypes.
33184027|a|Aging drives pathological accumulation of proteins such as tau, causing neurodegenerative dementia disorders like Alzheimer's disease. Previously we showed loss of function mutations in the gene encoding the poly(A) RNA binding protein SUT-2/MSUT2 suppress tau-mediated neurotoxicity in C. elegans neurons, cultured human cells, and mouse brain, while loss of PABPN1 had the opposite effect (Wheeler et al., 2019). Here we found that blocking poly(A) tail extension with cordycepin exacerbates tauopathy in cultured human cells, which is rescued by MSUT2 knockdown. To further investigate the molecular mechanisms of poly(A) RNA-mediated tauopathy suppression, we examined whether genes encoding poly(A) nucleases also modulated tauopathy in a C. elegans tauopathy model. We found that loss of function mutations in C. elegans ccr-4 and panl-2 genes enhanced tauopathy phenotypes in tau transgenic C. elegans while loss of parn-2 partially suppressed tauopathy. In addition, loss of parn-1 blocked tauopathy suppression by loss of parn-2. Epistasis analysis showed that sut-2 loss of function suppressed the tauopathy enhancement caused by loss of ccr-4 and SUT-2 overexpression exacerbated tauopathy even in the presence of parn-2 loss of function in tau transgenic C. elegans. Thus sut-2 modulation of tauopathy is epistatic to ccr-4 and parn-2. We found that human deadenylases do not colocalize with human MSUT2 in nuclear speckles; however, expression levels of TOE1, the homolog of parn-2, correlated with that of MSUT2 in post-mortem Alzheimer's disease patient brains. Alzheimer's disease patients with low TOE1 levels exhibited significantly increased pathological tau deposition and loss of NeuN staining. Taken together, this work suggests suppressing tauopathy cannot be accomplished by simply extending poly(A) tails, but rather a more complex relationship exists between tau, sut-2/MSUT2 function, and control of poly(A) RNA metabolism, and that parn-2/TOE1 may be altered in tauopathy in a similar way.
33184027	9	16	Poly(A)	Chemical	MESH:D011061
33184027	55	60	sut-2	Gene	178847
33184027	71	80	tauopathy	Disease	MESH:D024801
33184027	152	155	tau	Gene	4137
33184027	165	201	neurodegenerative dementia disorders	Disease	MESH:D019636
33184027	207	226	Alzheimer's disease	Disease	MESH:D000544
33184027	329	334	SUT-2	Gene	79882
33184027	335	340	MSUT2	Gene	79882
33184027	350	353	tau	Gene	4137
33184027	363	376	neurotoxicity	Disease	MESH:D020258
33184027	380	390	C. elegans	Species	328850
33184027	409	414	human	Species	9606
33184027	426	431	mouse	Species	10090
33184027	453	459	PABPN1	Gene	54196
33184027	536	543	poly(A)	Chemical	MESH:D011061
33184027	564	574	cordycepin	Chemical	MESH:C058120
33184027	587	596	tauopathy	Disease	MESH:D024801
33184027	609	614	human	Species	9606
33184027	642	647	MSUT2	Gene	79882
33184027	710	717	poly(A)	Chemical	MESH:D011061
33184027	731	740	tauopathy	Disease	MESH:D024801
33184027	789	796	poly(A)	Chemical	MESH:D011061
33184027	822	831	tauopathy	Disease	MESH:D024801
33184027	837	847	C. elegans	Species	328850
33184027	848	857	tauopathy	Disease	MESH:D024801
33184027	909	919	C. elegans	Species	328850
33184027	920	925	ccr-4	Gene	178184
33184027	930	936	panl-2	Gene	175974
33184027	952	961	tauopathy	Disease	MESH:D024801
33184027	976	979	tau	Gene	4137
33184027	991	1001	C. elegans	Species	328850
33184027	1016	1022	parn-2	Gene	174866
33184027	1044	1053	tauopathy	Disease	MESH:D024801
33184027	1076	1082	parn-1	Gene	187256
33184027	1091	1100	tauopathy	Disease	MESH:D024801
33184027	1124	1130	parn-2	Gene	174866
33184027	1163	1168	sut-2	Gene	178847
33184027	1201	1210	tauopathy	Disease	MESH:D024801
33184027	1241	1246	ccr-4	Gene	178184
33184027	1251	1256	SUT-2	Gene	178847
33184027	1284	1293	tauopathy	Disease	MESH:D024801
33184027	1318	1324	parn-2	Gene	174866
33184027	1345	1348	tau	Gene	4137
33184027	1360	1370	C. elegans	Species	328850
33184027	1377	1382	sut-2	Gene	178847
33184027	1397	1406	tauopathy	Disease	MESH:D024801
33184027	1423	1428	ccr-4	Gene	178184
33184027	1433	1439	parn-2	Gene	174866
33184027	1455	1460	human	Species	9606
33184027	1497	1502	human	Species	9606
33184027	1503	1508	MSUT2	Gene	79882
33184027	1560	1564	TOE1	Gene	114034
33184027	1581	1587	parn-2	Gene	174866
33184027	1613	1618	MSUT2	Gene	79882
33184027	1634	1653	Alzheimer's disease	Disease	MESH:D000544
33184027	1654	1661	patient	Species	9606
33184027	1670	1689	Alzheimer's disease	Disease	MESH:D000544
33184027	1690	1698	patients	Species	9606
33184027	1708	1712	TOE1	Gene	114034
33184027	1767	1770	tau	Gene	4137
33184027	1794	1798	NeuN	Gene	146713
33184027	1856	1865	tauopathy	Disease	MESH:D024801
33184027	1909	1916	poly(A)	Chemical	MESH:D011061
33184027	1978	1981	tau	Gene	4137
33184027	1983	1988	sut-2	Gene	79882
33184027	1989	1994	MSUT2	Gene	79882
33184027	2020	2027	poly(A)	Chemical	MESH:D011061
33184027	2053	2059	parn-2	Gene	174866
33184027	2060	2064	TOE1	Gene	114034
33184027	2083	2092	tauopathy	Disease	MESH:D024801
33184027	Association	MESH:D024801	178184
33184027	Positive_Correlation	MESH:C058120	MESH:D024801
33184027	Association	MESH:D024801	174866
33184027	Association	MESH:C058120	79882
33184027	Association	MESH:C058120	MESH:D011061
33184027	Association	MESH:D024801	187256
33184027	Association	MESH:D020258	4137
33184027	Negative_Correlation	114034	4137
33184027	Association	MESH:D011061	178847
33184027	Association	178184	178847
33184027	Association	174866	178847
33184027	Association	MESH:D000544	79882
33184027	Association	MESH:D019636	4137
33184027	Association	178847	79882
33184027	Association	MESH:D024801	79882
33184027	Negative_Correlation	MESH:D000544	146713
33184027	Negative_Correlation	4137	79882
33184027	Association	MESH:D011061	79882
33184027	Association	MESH:D000544	4137
33184027	Negative_Correlation	114034	146713
33184027	Association	MESH:D024801	178847
33184027	Association	MESH:D000544	114034
33184027	Association	MESH:D024801	175974
33184027	Negative_Correlation	MESH:D020258	79882
33184027	Association	174866	187256
33184027	Association	MESH:D011061	MESH:D024801

